nodes	percent_of_prediction	percent_of_DWPC	metapath
Terbinafine—CYP2C8—Sorafenib—liver cancer	0.0961	0.2	CbGbCtD
Terbinafine—CYP2C19—Sorafenib—liver cancer	0.0806	0.168	CbGbCtD
Terbinafine—CYP1A2—Sorafenib—liver cancer	0.0744	0.155	CbGbCtD
Terbinafine—CYP2C9—Sorafenib—liver cancer	0.067	0.14	CbGbCtD
Terbinafine—CYP2D6—Sorafenib—liver cancer	0.0613	0.128	CbGbCtD
Terbinafine—CYP3A4—Sorafenib—liver cancer	0.039	0.0813	CbGbCtD
Terbinafine—CYP2D6—Doxorubicin—liver cancer	0.0372	0.0776	CbGbCtD
Terbinafine—CYP3A4—Doxorubicin—liver cancer	0.0236	0.0493	CbGbCtD
Terbinafine—Psoriasis—Epirubicin—liver cancer	0.00193	0.00779	CcSEcCtD
Terbinafine—Neutropenia—Sorafenib—liver cancer	0.00193	0.00777	CcSEcCtD
Terbinafine—Skin hyperpigmentation—Doxorubicin—liver cancer	0.00189	0.00761	CcSEcCtD
Terbinafine—Weight decreased—Sorafenib—liver cancer	0.00187	0.00752	CcSEcCtD
Terbinafine—Infestation NOS—Sorafenib—liver cancer	0.00184	0.00741	CcSEcCtD
Terbinafine—Infestation—Sorafenib—liver cancer	0.00184	0.00741	CcSEcCtD
Terbinafine—Eruption—Doxorubicin—liver cancer	0.00183	0.00736	CcSEcCtD
Terbinafine—Stevens-Johnson syndrome—Sorafenib—liver cancer	0.00182	0.00735	CcSEcCtD
Terbinafine—Redness—Epirubicin—liver cancer	0.0018	0.00725	CcSEcCtD
Terbinafine—Jaundice—Sorafenib—liver cancer	0.00179	0.00722	CcSEcCtD
Terbinafine—Psoriasis—Doxorubicin—liver cancer	0.00179	0.00721	CcSEcCtD
Terbinafine—Hepatobiliary disease—Sorafenib—liver cancer	0.00174	0.00701	CcSEcCtD
Terbinafine—Redness—Doxorubicin—liver cancer	0.00167	0.00671	CcSEcCtD
Terbinafine—Connective tissue disorder—Sorafenib—liver cancer	0.00162	0.00654	CcSEcCtD
Terbinafine—Scotoma—Epirubicin—liver cancer	0.0016	0.00645	CcSEcCtD
Terbinafine—Rash erythematous—Epirubicin—liver cancer	0.00159	0.00639	CcSEcCtD
Terbinafine—Erythema multiforme—Sorafenib—liver cancer	0.00156	0.00629	CcSEcCtD
Terbinafine—Tinnitus—Sorafenib—liver cancer	0.00154	0.0062	CcSEcCtD
Terbinafine—Ageusia—Epirubicin—liver cancer	0.0015	0.00604	CcSEcCtD
Terbinafine—Stinging—Epirubicin—liver cancer	0.0015	0.00604	CcSEcCtD
Terbinafine—Angiopathy—Sorafenib—liver cancer	0.0015	0.00603	CcSEcCtD
Terbinafine—Immune system disorder—Sorafenib—liver cancer	0.00149	0.00601	CcSEcCtD
Terbinafine—Scotoma—Doxorubicin—liver cancer	0.00148	0.00596	CcSEcCtD
Terbinafine—Rash erythematous—Doxorubicin—liver cancer	0.00147	0.00591	CcSEcCtD
Terbinafine—Alopecia—Sorafenib—liver cancer	0.00146	0.00588	CcSEcCtD
Terbinafine—Blood disorder—Epirubicin—liver cancer	0.00145	0.00586	CcSEcCtD
Terbinafine—Mental disorder—Sorafenib—liver cancer	0.00145	0.00583	CcSEcCtD
Terbinafine—Liver injury—Epirubicin—liver cancer	0.00144	0.00582	CcSEcCtD
Terbinafine—Erythema—Sorafenib—liver cancer	0.00144	0.00579	CcSEcCtD
Terbinafine—Dysgeusia—Sorafenib—liver cancer	0.00141	0.00567	CcSEcCtD
Terbinafine—Stinging—Doxorubicin—liver cancer	0.00139	0.00559	CcSEcCtD
Terbinafine—Ageusia—Doxorubicin—liver cancer	0.00139	0.00559	CcSEcCtD
Terbinafine—Jaundice cholestatic—Epirubicin—liver cancer	0.00138	0.00557	CcSEcCtD
Terbinafine—Muscle spasms—Sorafenib—liver cancer	0.00138	0.00557	CcSEcCtD
Terbinafine—Blood disorder—Doxorubicin—liver cancer	0.00135	0.00542	CcSEcCtD
Terbinafine—Skin discolouration—Epirubicin—liver cancer	0.00134	0.00542	CcSEcCtD
Terbinafine—Liver injury—Doxorubicin—liver cancer	0.00134	0.00538	CcSEcCtD
Terbinafine—Anaemia—Sorafenib—liver cancer	0.00133	0.00535	CcSEcCtD
Terbinafine—Angioedema—Sorafenib—liver cancer	0.00131	0.00529	CcSEcCtD
Terbinafine—Jaundice cholestatic—Doxorubicin—liver cancer	0.00128	0.00515	CcSEcCtD
Terbinafine—Cough—Sorafenib—liver cancer	0.00125	0.00505	CcSEcCtD
Terbinafine—Skin discolouration—Doxorubicin—liver cancer	0.00124	0.00501	CcSEcCtD
Terbinafine—Arthralgia—Sorafenib—liver cancer	0.00122	0.00493	CcSEcCtD
Terbinafine—Myalgia—Sorafenib—liver cancer	0.00122	0.00493	CcSEcCtD
Terbinafine—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.00121	0.0049	CcSEcCtD
Terbinafine—Hepatocellular injury—Epirubicin—liver cancer	0.00121	0.00489	CcSEcCtD
Terbinafine—Dermatitis contact—Epirubicin—liver cancer	0.0012	0.00484	CcSEcCtD
Terbinafine—Dry mouth—Sorafenib—liver cancer	0.0012	0.00482	CcSEcCtD
Terbinafine—Eructation—Epirubicin—liver cancer	0.00119	0.00481	CcSEcCtD
Terbinafine—Influenza like illness—Epirubicin—liver cancer	0.00118	0.00475	CcSEcCtD
Terbinafine—Anaphylactic shock—Sorafenib—liver cancer	0.00117	0.00473	CcSEcCtD
Terbinafine—Infection—Sorafenib—liver cancer	0.00117	0.00469	CcSEcCtD
Terbinafine—Skin exfoliation—Epirubicin—liver cancer	0.00116	0.00467	CcSEcCtD
Terbinafine—Nervous system disorder—Sorafenib—liver cancer	0.00115	0.00463	CcSEcCtD
Terbinafine—Thrombocytopenia—Sorafenib—liver cancer	0.00115	0.00463	CcSEcCtD
Terbinafine—Blood urea increased—Epirubicin—liver cancer	0.00115	0.00462	CcSEcCtD
Terbinafine—Skin disorder—Sorafenib—liver cancer	0.00114	0.00459	CcSEcCtD
Terbinafine—Hepatocellular injury—Doxorubicin—liver cancer	0.00112	0.00453	CcSEcCtD
Terbinafine—Anorexia—Sorafenib—liver cancer	0.00112	0.0045	CcSEcCtD
Terbinafine—Dermatitis contact—Doxorubicin—liver cancer	0.00111	0.00448	CcSEcCtD
Terbinafine—Eructation—Doxorubicin—liver cancer	0.0011	0.00445	CcSEcCtD
Terbinafine—Influenza like illness—Doxorubicin—liver cancer	0.00109	0.0044	CcSEcCtD
Terbinafine—Skin exfoliation—Doxorubicin—liver cancer	0.00107	0.00432	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00107	0.0043	CcSEcCtD
Terbinafine—Blood urea increased—Doxorubicin—liver cancer	0.00106	0.00428	CcSEcCtD
Terbinafine—Dyspepsia—Sorafenib—liver cancer	0.00103	0.00416	CcSEcCtD
Terbinafine—Decreased appetite—Sorafenib—liver cancer	0.00102	0.00411	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Sorafenib—liver cancer	0.00101	0.00408	CcSEcCtD
Terbinafine—Fatigue—Sorafenib—liver cancer	0.00101	0.00407	CcSEcCtD
Terbinafine—Hepatic function abnormal—Epirubicin—liver cancer	0.00101	0.00407	CcSEcCtD
Terbinafine—Photosensitivity—Epirubicin—liver cancer	0.001	0.00405	CcSEcCtD
Terbinafine—Pain—Sorafenib—liver cancer	0.001	0.00404	CcSEcCtD
Terbinafine—Eczema—Epirubicin—liver cancer	0.000981	0.00395	CcSEcCtD
Terbinafine—Hepatic failure—Epirubicin—liver cancer	0.000981	0.00395	CcSEcCtD
Terbinafine—Gastrointestinal pain—Sorafenib—liver cancer	0.000959	0.00386	CcSEcCtD
Terbinafine—Dermatitis exfoliative—Epirubicin—liver cancer	0.000935	0.00377	CcSEcCtD
Terbinafine—Hepatic function abnormal—Doxorubicin—liver cancer	0.000934	0.00376	CcSEcCtD
Terbinafine—Urticaria—Sorafenib—liver cancer	0.000932	0.00375	CcSEcCtD
Terbinafine—Photosensitivity—Doxorubicin—liver cancer	0.000929	0.00374	CcSEcCtD
Terbinafine—Body temperature increased—Sorafenib—liver cancer	0.000927	0.00374	CcSEcCtD
Terbinafine—Abdominal pain—Sorafenib—liver cancer	0.000927	0.00374	CcSEcCtD
Terbinafine—Dermatitis bullous—Epirubicin—liver cancer	0.000923	0.00372	CcSEcCtD
Terbinafine—Anaphylactoid reaction—Epirubicin—liver cancer	0.000911	0.00367	CcSEcCtD
Terbinafine—Hepatic failure—Doxorubicin—liver cancer	0.000908	0.00366	CcSEcCtD
Terbinafine—Eczema—Doxorubicin—liver cancer	0.000908	0.00366	CcSEcCtD
Terbinafine—Hypoglycaemia—Epirubicin—liver cancer	0.000904	0.00364	CcSEcCtD
Terbinafine—Dermatitis exfoliative—Doxorubicin—liver cancer	0.000865	0.00348	CcSEcCtD
Terbinafine—Hypersensitivity—Sorafenib—liver cancer	0.000864	0.00348	CcSEcCtD
Terbinafine—Dermatitis bullous—Doxorubicin—liver cancer	0.000854	0.00344	CcSEcCtD
Terbinafine—Anaphylactoid reaction—Doxorubicin—liver cancer	0.000843	0.0034	CcSEcCtD
Terbinafine—Asthenia—Sorafenib—liver cancer	0.000841	0.00339	CcSEcCtD
Terbinafine—Hypoglycaemia—Doxorubicin—liver cancer	0.000836	0.00337	CcSEcCtD
Terbinafine—Pruritus—Sorafenib—liver cancer	0.00083	0.00334	CcSEcCtD
Terbinafine—Abdominal pain upper—Epirubicin—liver cancer	0.000805	0.00325	CcSEcCtD
Terbinafine—Diarrhoea—Sorafenib—liver cancer	0.000802	0.00323	CcSEcCtD
Terbinafine—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.000794	0.0032	CcSEcCtD
Terbinafine—Nasopharyngitis—Epirubicin—liver cancer	0.000789	0.00318	CcSEcCtD
Terbinafine—Gastritis—Epirubicin—liver cancer	0.00078	0.00314	CcSEcCtD
Terbinafine—Dizziness—Sorafenib—liver cancer	0.000776	0.00312	CcSEcCtD
Terbinafine—Influenza—Epirubicin—liver cancer	0.000762	0.00307	CcSEcCtD
Terbinafine—Eosinophilia—Epirubicin—liver cancer	0.000755	0.00304	CcSEcCtD
Terbinafine—Pancreatitis—Epirubicin—liver cancer	0.000747	0.00301	CcSEcCtD
Terbinafine—Vomiting—Sorafenib—liver cancer	0.000746	0.003	CcSEcCtD
Terbinafine—Abdominal pain upper—Doxorubicin—liver cancer	0.000745	0.003	CcSEcCtD
Terbinafine—Rash—Sorafenib—liver cancer	0.000739	0.00298	CcSEcCtD
Terbinafine—Dermatitis—Sorafenib—liver cancer	0.000739	0.00298	CcSEcCtD
Terbinafine—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.000735	0.00296	CcSEcCtD
Terbinafine—Headache—Sorafenib—liver cancer	0.000735	0.00296	CcSEcCtD
Terbinafine—Nasopharyngitis—Doxorubicin—liver cancer	0.00073	0.00294	CcSEcCtD
Terbinafine—Pancytopenia—Epirubicin—liver cancer	0.000724	0.00292	CcSEcCtD
Terbinafine—Gastritis—Doxorubicin—liver cancer	0.000722	0.00291	CcSEcCtD
Terbinafine—Neutropenia—Epirubicin—liver cancer	0.000713	0.00287	CcSEcCtD
Terbinafine—Upper respiratory tract infection—Epirubicin—liver cancer	0.000708	0.00285	CcSEcCtD
Terbinafine—Influenza—Doxorubicin—liver cancer	0.000705	0.00284	CcSEcCtD
Terbinafine—Eosinophilia—Doxorubicin—liver cancer	0.000698	0.00281	CcSEcCtD
Terbinafine—Nausea—Sorafenib—liver cancer	0.000697	0.00281	CcSEcCtD
Terbinafine—Photosensitivity reaction—Epirubicin—liver cancer	0.000696	0.0028	CcSEcCtD
Terbinafine—Pancreatitis—Doxorubicin—liver cancer	0.000691	0.00279	CcSEcCtD
Terbinafine—Weight decreased—Epirubicin—liver cancer	0.00069	0.00278	CcSEcCtD
Terbinafine—Infestation NOS—Epirubicin—liver cancer	0.00068	0.00274	CcSEcCtD
Terbinafine—Infestation—Epirubicin—liver cancer	0.00068	0.00274	CcSEcCtD
Terbinafine—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.000674	0.00271	CcSEcCtD
Terbinafine—Pancytopenia—Doxorubicin—liver cancer	0.00067	0.0027	CcSEcCtD
Terbinafine—Jaundice—Epirubicin—liver cancer	0.000662	0.00267	CcSEcCtD
Terbinafine—Neutropenia—Doxorubicin—liver cancer	0.000659	0.00266	CcSEcCtD
Terbinafine—Upper respiratory tract infection—Doxorubicin—liver cancer	0.000655	0.00264	CcSEcCtD
Terbinafine—Photosensitivity reaction—Doxorubicin—liver cancer	0.000644	0.00259	CcSEcCtD
Terbinafine—Hepatobiliary disease—Epirubicin—liver cancer	0.000643	0.00259	CcSEcCtD
Terbinafine—Weight decreased—Doxorubicin—liver cancer	0.000638	0.00257	CcSEcCtD
Terbinafine—Agranulocytosis—Epirubicin—liver cancer	0.000634	0.00256	CcSEcCtD
Terbinafine—Infestation—Doxorubicin—liver cancer	0.000629	0.00253	CcSEcCtD
Terbinafine—Infestation NOS—Doxorubicin—liver cancer	0.000629	0.00253	CcSEcCtD
Terbinafine—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.000623	0.00251	CcSEcCtD
Terbinafine—Jaundice—Doxorubicin—liver cancer	0.000613	0.00247	CcSEcCtD
Terbinafine—Hepatitis—Epirubicin—liver cancer	0.00061	0.00246	CcSEcCtD
Terbinafine—Hypoaesthesia—Epirubicin—liver cancer	0.000607	0.00245	CcSEcCtD
Terbinafine—Connective tissue disorder—Epirubicin—liver cancer	0.000599	0.00242	CcSEcCtD
Terbinafine—Hepatobiliary disease—Doxorubicin—liver cancer	0.000595	0.0024	CcSEcCtD
Terbinafine—Visual impairment—Epirubicin—liver cancer	0.000588	0.00237	CcSEcCtD
Terbinafine—Agranulocytosis—Doxorubicin—liver cancer	0.000587	0.00236	CcSEcCtD
Terbinafine—Erythema multiforme—Epirubicin—liver cancer	0.000577	0.00232	CcSEcCtD
Terbinafine—Eye disorder—Epirubicin—liver cancer	0.00057	0.0023	CcSEcCtD
Terbinafine—Tinnitus—Epirubicin—liver cancer	0.000569	0.00229	CcSEcCtD
Terbinafine—Hepatitis—Doxorubicin—liver cancer	0.000564	0.00227	CcSEcCtD
Terbinafine—Hypoaesthesia—Doxorubicin—liver cancer	0.000562	0.00226	CcSEcCtD
Terbinafine—Connective tissue disorder—Doxorubicin—liver cancer	0.000555	0.00223	CcSEcCtD
Terbinafine—Angiopathy—Epirubicin—liver cancer	0.000553	0.00223	CcSEcCtD
Terbinafine—Immune system disorder—Epirubicin—liver cancer	0.000551	0.00222	CcSEcCtD
Terbinafine—Visual impairment—Doxorubicin—liver cancer	0.000544	0.00219	CcSEcCtD
Terbinafine—Alopecia—Epirubicin—liver cancer	0.000539	0.00217	CcSEcCtD
Terbinafine—Mental disorder—Epirubicin—liver cancer	0.000534	0.00215	CcSEcCtD
Terbinafine—Erythema multiforme—Doxorubicin—liver cancer	0.000534	0.00215	CcSEcCtD
Terbinafine—Erythema—Epirubicin—liver cancer	0.000531	0.00214	CcSEcCtD
Terbinafine—Eye disorder—Doxorubicin—liver cancer	0.000528	0.00213	CcSEcCtD
Terbinafine—Tinnitus—Doxorubicin—liver cancer	0.000526	0.00212	CcSEcCtD
Terbinafine—Flatulence—Epirubicin—liver cancer	0.000523	0.00211	CcSEcCtD
Terbinafine—Dysgeusia—Epirubicin—liver cancer	0.00052	0.0021	CcSEcCtD
Terbinafine—Angiopathy—Doxorubicin—liver cancer	0.000512	0.00206	CcSEcCtD
Terbinafine—Muscle spasms—Epirubicin—liver cancer	0.000511	0.00206	CcSEcCtD
Terbinafine—Immune system disorder—Doxorubicin—liver cancer	0.00051	0.00205	CcSEcCtD
Terbinafine—Vision blurred—Epirubicin—liver cancer	0.0005	0.00202	CcSEcCtD
Terbinafine—Alopecia—Doxorubicin—liver cancer	0.000499	0.00201	CcSEcCtD
Terbinafine—Mental disorder—Doxorubicin—liver cancer	0.000495	0.00199	CcSEcCtD
Terbinafine—Ill-defined disorder—Epirubicin—liver cancer	0.000493	0.00199	CcSEcCtD
Terbinafine—Erythema—Doxorubicin—liver cancer	0.000491	0.00198	CcSEcCtD
Terbinafine—Anaemia—Epirubicin—liver cancer	0.000491	0.00198	CcSEcCtD
Terbinafine—Flatulence—Doxorubicin—liver cancer	0.000484	0.00195	CcSEcCtD
Terbinafine—Dysgeusia—Doxorubicin—liver cancer	0.000481	0.00194	CcSEcCtD
Terbinafine—Malaise—Epirubicin—liver cancer	0.000479	0.00193	CcSEcCtD
Terbinafine—Vertigo—Epirubicin—liver cancer	0.000477	0.00192	CcSEcCtD
Terbinafine—Muscle spasms—Doxorubicin—liver cancer	0.000472	0.0019	CcSEcCtD
Terbinafine—Cough—Epirubicin—liver cancer	0.000463	0.00187	CcSEcCtD
Terbinafine—Vision blurred—Doxorubicin—liver cancer	0.000463	0.00187	CcSEcCtD
Terbinafine—Ill-defined disorder—Doxorubicin—liver cancer	0.000456	0.00184	CcSEcCtD
Terbinafine—Anaemia—Doxorubicin—liver cancer	0.000454	0.00183	CcSEcCtD
Terbinafine—Myalgia—Epirubicin—liver cancer	0.000452	0.00182	CcSEcCtD
Terbinafine—Chest pain—Epirubicin—liver cancer	0.000452	0.00182	CcSEcCtD
Terbinafine—Arthralgia—Epirubicin—liver cancer	0.000452	0.00182	CcSEcCtD
Terbinafine—Anxiety—Epirubicin—liver cancer	0.000451	0.00182	CcSEcCtD
Terbinafine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000449	0.00181	CcSEcCtD
Terbinafine—Discomfort—Epirubicin—liver cancer	0.000447	0.0018	CcSEcCtD
Terbinafine—Malaise—Doxorubicin—liver cancer	0.000443	0.00179	CcSEcCtD
Terbinafine—Dry mouth—Epirubicin—liver cancer	0.000442	0.00178	CcSEcCtD
Terbinafine—Vertigo—Doxorubicin—liver cancer	0.000441	0.00178	CcSEcCtD
Terbinafine—Confusional state—Epirubicin—liver cancer	0.000437	0.00176	CcSEcCtD
Terbinafine—Anaphylactic shock—Epirubicin—liver cancer	0.000433	0.00175	CcSEcCtD
Terbinafine—Infection—Epirubicin—liver cancer	0.000431	0.00173	CcSEcCtD
Terbinafine—Cough—Doxorubicin—liver cancer	0.000429	0.00173	CcSEcCtD
Terbinafine—Nervous system disorder—Epirubicin—liver cancer	0.000425	0.00171	CcSEcCtD
Terbinafine—Thrombocytopenia—Epirubicin—liver cancer	0.000424	0.00171	CcSEcCtD
Terbinafine—Skin disorder—Epirubicin—liver cancer	0.000421	0.0017	CcSEcCtD
Terbinafine—Chest pain—Doxorubicin—liver cancer	0.000418	0.00169	CcSEcCtD
Terbinafine—Myalgia—Doxorubicin—liver cancer	0.000418	0.00169	CcSEcCtD
Terbinafine—Arthralgia—Doxorubicin—liver cancer	0.000418	0.00169	CcSEcCtD
Terbinafine—Anxiety—Doxorubicin—liver cancer	0.000417	0.00168	CcSEcCtD
Terbinafine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000415	0.00167	CcSEcCtD
Terbinafine—Discomfort—Doxorubicin—liver cancer	0.000413	0.00167	CcSEcCtD
Terbinafine—Anorexia—Epirubicin—liver cancer	0.000413	0.00166	CcSEcCtD
Terbinafine—Dry mouth—Doxorubicin—liver cancer	0.000409	0.00165	CcSEcCtD
Terbinafine—Confusional state—Doxorubicin—liver cancer	0.000404	0.00163	CcSEcCtD
Terbinafine—Anaphylactic shock—Doxorubicin—liver cancer	0.000401	0.00162	CcSEcCtD
Terbinafine—Infection—Doxorubicin—liver cancer	0.000398	0.00161	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000395	0.00159	CcSEcCtD
Terbinafine—Nervous system disorder—Doxorubicin—liver cancer	0.000393	0.00158	CcSEcCtD
Terbinafine—Thrombocytopenia—Doxorubicin—liver cancer	0.000393	0.00158	CcSEcCtD
Terbinafine—Skin disorder—Doxorubicin—liver cancer	0.00039	0.00157	CcSEcCtD
Terbinafine—Paraesthesia—Epirubicin—liver cancer	0.000389	0.00157	CcSEcCtD
Terbinafine—Anorexia—Doxorubicin—liver cancer	0.000382	0.00154	CcSEcCtD
Terbinafine—Dyspepsia—Epirubicin—liver cancer	0.000382	0.00154	CcSEcCtD
Terbinafine—Decreased appetite—Epirubicin—liver cancer	0.000377	0.00152	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Epirubicin—liver cancer	0.000374	0.00151	CcSEcCtD
Terbinafine—Fatigue—Epirubicin—liver cancer	0.000374	0.00151	CcSEcCtD
Terbinafine—Pain—Epirubicin—liver cancer	0.000371	0.00149	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000365	0.00147	CcSEcCtD
Terbinafine—Paraesthesia—Doxorubicin—liver cancer	0.00036	0.00145	CcSEcCtD
Terbinafine—Feeling abnormal—Epirubicin—liver cancer	0.000357	0.00144	CcSEcCtD
Terbinafine—Gastrointestinal pain—Epirubicin—liver cancer	0.000354	0.00143	CcSEcCtD
Terbinafine—Dyspepsia—Doxorubicin—liver cancer	0.000353	0.00142	CcSEcCtD
Terbinafine—Decreased appetite—Doxorubicin—liver cancer	0.000349	0.0014	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000346	0.00139	CcSEcCtD
Terbinafine—Fatigue—Doxorubicin—liver cancer	0.000346	0.00139	CcSEcCtD
Terbinafine—Urticaria—Epirubicin—liver cancer	0.000344	0.00139	CcSEcCtD
Terbinafine—Pain—Doxorubicin—liver cancer	0.000343	0.00138	CcSEcCtD
Terbinafine—Body temperature increased—Epirubicin—liver cancer	0.000343	0.00138	CcSEcCtD
Terbinafine—Abdominal pain—Epirubicin—liver cancer	0.000343	0.00138	CcSEcCtD
Terbinafine—Feeling abnormal—Doxorubicin—liver cancer	0.00033	0.00133	CcSEcCtD
Terbinafine—Gastrointestinal pain—Doxorubicin—liver cancer	0.000328	0.00132	CcSEcCtD
Terbinafine—Hypersensitivity—Epirubicin—liver cancer	0.000319	0.00129	CcSEcCtD
Terbinafine—Urticaria—Doxorubicin—liver cancer	0.000319	0.00128	CcSEcCtD
Terbinafine—Abdominal pain—Doxorubicin—liver cancer	0.000317	0.00128	CcSEcCtD
Terbinafine—Body temperature increased—Doxorubicin—liver cancer	0.000317	0.00128	CcSEcCtD
Terbinafine—Asthenia—Epirubicin—liver cancer	0.000311	0.00125	CcSEcCtD
Terbinafine—Pruritus—Epirubicin—liver cancer	0.000307	0.00124	CcSEcCtD
Terbinafine—Diarrhoea—Epirubicin—liver cancer	0.000297	0.00119	CcSEcCtD
Terbinafine—Hypersensitivity—Doxorubicin—liver cancer	0.000295	0.00119	CcSEcCtD
Terbinafine—Asthenia—Doxorubicin—liver cancer	0.000288	0.00116	CcSEcCtD
Terbinafine—Dizziness—Epirubicin—liver cancer	0.000287	0.00115	CcSEcCtD
Terbinafine—Pruritus—Doxorubicin—liver cancer	0.000284	0.00114	CcSEcCtD
Terbinafine—Vomiting—Epirubicin—liver cancer	0.000276	0.00111	CcSEcCtD
Terbinafine—Diarrhoea—Doxorubicin—liver cancer	0.000274	0.00111	CcSEcCtD
Terbinafine—Rash—Epirubicin—liver cancer	0.000273	0.0011	CcSEcCtD
Terbinafine—Dermatitis—Epirubicin—liver cancer	0.000273	0.0011	CcSEcCtD
Terbinafine—Headache—Epirubicin—liver cancer	0.000272	0.00109	CcSEcCtD
Terbinafine—Dizziness—Doxorubicin—liver cancer	0.000265	0.00107	CcSEcCtD
Terbinafine—Nausea—Epirubicin—liver cancer	0.000257	0.00104	CcSEcCtD
Terbinafine—Vomiting—Doxorubicin—liver cancer	0.000255	0.00103	CcSEcCtD
Terbinafine—Rash—Doxorubicin—liver cancer	0.000253	0.00102	CcSEcCtD
Terbinafine—Dermatitis—Doxorubicin—liver cancer	0.000253	0.00102	CcSEcCtD
Terbinafine—Headache—Doxorubicin—liver cancer	0.000251	0.00101	CcSEcCtD
Terbinafine—Nausea—Doxorubicin—liver cancer	0.000238	0.00096	CcSEcCtD
Terbinafine—CYP2D6—Metabolism—CPT1B—liver cancer	4.59e-05	0.000169	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—GLUL—liver cancer	4.59e-05	0.000169	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—PIK3CG—liver cancer	4.59e-05	0.000169	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—GSTA1—liver cancer	4.56e-05	0.000167	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—GLUL—liver cancer	4.55e-05	0.000167	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—CPT1B—liver cancer	4.55e-05	0.000167	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—CYP2E1—liver cancer	4.55e-05	0.000167	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—NAT2—liver cancer	4.51e-05	0.000165	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—GSTP1—liver cancer	4.46e-05	0.000164	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—PPARG—liver cancer	4.43e-05	0.000163	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—NR1H4—liver cancer	4.43e-05	0.000163	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—TAT—liver cancer	4.42e-05	0.000162	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	4.4e-05	0.000162	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—HMOX1—liver cancer	4.4e-05	0.000161	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—NR1H4—liver cancer	4.39e-05	0.000161	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—GSTA3—liver cancer	4.35e-05	0.00016	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—liver cancer	4.34e-05	0.000159	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—GSTA4—liver cancer	4.33e-05	0.000159	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—ALDOB—liver cancer	4.32e-05	0.000159	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—GSTA3—liver cancer	4.32e-05	0.000158	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—CYCS—liver cancer	4.26e-05	0.000156	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	4.23e-05	0.000155	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—GSTA2—liver cancer	4.22e-05	0.000155	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—liver cancer	4.21e-05	0.000155	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—GGT1—liver cancer	4.18e-05	0.000153	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—GOT1—liver cancer	4.18e-05	0.000153	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—CRABP1—liver cancer	4.12e-05	0.000151	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—GSTM1—liver cancer	4.1e-05	0.00015	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—GSTA1—liver cancer	4.07e-05	0.000149	CbGpPWpGaD
Terbinafine—SQLE—Metabolism—AKT1—liver cancer	4.05e-05	0.000149	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—PIK3CD—liver cancer	4.04e-05	0.000148	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—NAT2—liver cancer	4.02e-05	0.000148	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—ALB—liver cancer	3.98e-05	0.000146	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—GSTA4—liver cancer	3.98e-05	0.000146	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—GSTA4—liver cancer	3.95e-05	0.000145	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—CPT1B—liver cancer	3.89e-05	0.000143	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—GLUL—liver cancer	3.89e-05	0.000143	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—CYP1A1—liver cancer	3.88e-05	0.000143	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—GSTA2—liver cancer	3.88e-05	0.000142	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—liver cancer	3.87e-05	0.000142	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—ALDOB—liver cancer	3.86e-05	0.000142	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	3.86e-05	0.000142	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—GSTA2—liver cancer	3.85e-05	0.000141	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—GSTP1—liver cancer	3.75e-05	0.000138	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—NR1H4—liver cancer	3.75e-05	0.000138	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—GSTA1—liver cancer	3.74e-05	0.000137	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	3.71e-05	0.000136	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—GSTA1—liver cancer	3.71e-05	0.000136	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—NAT2—liver cancer	3.7e-05	0.000136	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—HMOX1—liver cancer	3.7e-05	0.000136	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—GSTA3—liver cancer	3.69e-05	0.000135	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—CRABP1—liver cancer	3.68e-05	0.000135	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—NAT2—liver cancer	3.67e-05	0.000135	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—MTHFR—liver cancer	3.62e-05	0.000133	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—HPGDS—liver cancer	3.6e-05	0.000132	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—liver cancer	3.58e-05	0.000132	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—PPARA—liver cancer	3.55e-05	0.00013	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—ALDOB—liver cancer	3.55e-05	0.00013	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—liver cancer	3.53e-05	0.00013	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—ALDOB—liver cancer	3.52e-05	0.000129	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—PIK3CB—liver cancer	3.52e-05	0.000129	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—GSTM1—liver cancer	3.45e-05	0.000127	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—CRABP1—liver cancer	3.39e-05	0.000124	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—GSTA4—liver cancer	3.37e-05	0.000124	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—CRABP1—liver cancer	3.36e-05	0.000123	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	3.31e-05	0.000122	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	3.3e-05	0.000121	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—GSTA2—liver cancer	3.29e-05	0.000121	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—CYP1A1—liver cancer	3.27e-05	0.00012	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	3.26e-05	0.00012	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—liver cancer	3.22e-05	0.000118	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—HPGDS—liver cancer	3.22e-05	0.000118	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—PSMD10—liver cancer	3.21e-05	0.000118	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—PSMA4—liver cancer	3.21e-05	0.000118	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—liver cancer	3.2e-05	0.000117	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	3.19e-05	0.000117	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—GSTA1—liver cancer	3.17e-05	0.000116	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—NAT2—liver cancer	3.14e-05	0.000115	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—GOT2—liver cancer	3.13e-05	0.000115	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—MTHFR—liver cancer	3.05e-05	0.000112	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—PIK3CG—liver cancer	3.04e-05	0.000112	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	3.02e-05	0.000111	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	3.02e-05	0.000111	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—ALDOB—liver cancer	3.01e-05	0.00011	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—GLUL—liver cancer	3e-05	0.00011	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—CPT1B—liver cancer	3e-05	0.00011	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—PPARA—liver cancer	2.99e-05	0.00011	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—HPGDS—liver cancer	2.96e-05	0.000109	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—CYP2E1—liver cancer	2.94e-05	0.000108	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—PPARG—liver cancer	2.94e-05	0.000108	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—HPGDS—liver cancer	2.93e-05	0.000108	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.92e-05	0.000107	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	2.91e-05	0.000107	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—NR1H4—liver cancer	2.9e-05	0.000106	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—liver cancer	2.88e-05	0.000106	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—CRABP1—liver cancer	2.87e-05	0.000105	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—PSMA4—liver cancer	2.87e-05	0.000105	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—PSMD10—liver cancer	2.87e-05	0.000105	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—GSTA3—liver cancer	2.85e-05	0.000104	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	2.85e-05	0.000104	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—GOT2—liver cancer	2.79e-05	0.000102	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—CYCS—liver cancer	2.75e-05	0.000101	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—GOT1—liver cancer	2.7e-05	9.9e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—GGT1—liver cancer	2.7e-05	9.9e-05	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.69e-05	9.85e-05	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—PIK3CD—liver cancer	2.67e-05	9.81e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	2.66e-05	9.75e-05	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—ALB—liver cancer	2.64e-05	9.69e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—PSMA4—liver cancer	2.64e-05	9.68e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—PSMD10—liver cancer	2.64e-05	9.68e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—CYP2E1—liver cancer	2.62e-05	9.63e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	2.62e-05	9.63e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—PSMD10—liver cancer	2.61e-05	9.6e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—PSMA4—liver cancer	2.61e-05	9.6e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—GSTA4—liver cancer	2.6e-05	9.55e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.58e-05	9.48e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—GOT2—liver cancer	2.57e-05	9.42e-05	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—PIK3CG—liver cancer	2.56e-05	9.4e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—GOT2—liver cancer	2.54e-05	9.34e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	2.54e-05	9.32e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—GSTA2—liver cancer	2.54e-05	9.31e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—HPGDS—liver cancer	2.51e-05	9.2e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.49e-05	9.15e-05	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—PPARG—liver cancer	2.47e-05	9.07e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—CYCS—liver cancer	2.45e-05	9.01e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—GSTA1—liver cancer	2.45e-05	8.98e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—GSTP1—liver cancer	2.42e-05	8.89e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—NAT2—liver cancer	2.42e-05	8.88e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—CYP2E1—liver cancer	2.41e-05	8.85e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—GGT1—liver cancer	2.41e-05	8.84e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—GOT1—liver cancer	2.41e-05	8.84e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—CYP2E1—liver cancer	2.39e-05	8.78e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—HMOX1—liver cancer	2.39e-05	8.77e-05	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—PIK3CB—liver cancer	2.33e-05	8.55e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—ALDOB—liver cancer	2.32e-05	8.52e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	2.32e-05	8.5e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	2.27e-05	8.33e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—CYCS—liver cancer	2.26e-05	8.28e-05	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—PIK3CD—liver cancer	2.25e-05	8.26e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	2.24e-05	8.23e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—CYCS—liver cancer	2.24e-05	8.21e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—PSMA4—liver cancer	2.23e-05	8.2e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—PSMD10—liver cancer	2.23e-05	8.2e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—GSTM1—liver cancer	2.23e-05	8.17e-05	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—ALB—liver cancer	2.22e-05	8.15e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—GGT1—liver cancer	2.21e-05	8.13e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—GOT1—liver cancer	2.21e-05	8.13e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—CRABP1—liver cancer	2.21e-05	8.12e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—GOT1—liver cancer	2.2e-05	8.06e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—GGT1—liver cancer	2.2e-05	8.06e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—GOT2—liver cancer	2.17e-05	7.98e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—GSTP1—liver cancer	2.16e-05	7.94e-05	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—PIK3CA—liver cancer	2.14e-05	7.87e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—HMOX1—liver cancer	2.13e-05	7.83e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—CYP1A1—liver cancer	2.11e-05	7.75e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—CYP2E1—liver cancer	2.04e-05	7.5e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—GSTP1—liver cancer	1.99e-05	7.3e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—GSTM1—liver cancer	1.99e-05	7.3e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.98e-05	7.26e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—GSTP1—liver cancer	1.97e-05	7.24e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—MTHFR—liver cancer	1.97e-05	7.22e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—HMOX1—liver cancer	1.96e-05	7.2e-05	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—PIK3CB—liver cancer	1.96e-05	7.2e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—HMOX1—liver cancer	1.95e-05	7.14e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—HPGDS—liver cancer	1.93e-05	7.1e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—PPARA—liver cancer	1.93e-05	7.09e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—CYCS—liver cancer	1.91e-05	7.02e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—CYP1A1—liver cancer	1.88e-05	6.92e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—GOT1—liver cancer	1.88e-05	6.89e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—GGT1—liver cancer	1.88e-05	6.89e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—GSTM1—liver cancer	1.83e-05	6.71e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—GSTM1—liver cancer	1.81e-05	6.65e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—MTHFR—liver cancer	1.76e-05	6.45e-05	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—AKT1—liver cancer	1.75e-05	6.43e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.73e-05	6.37e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—CYP1A1—liver cancer	1.73e-05	6.36e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—PSMA4—liver cancer	1.72e-05	6.33e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—PSMD10—liver cancer	1.72e-05	6.33e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—PPARA—liver cancer	1.72e-05	6.33e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—CYP1A1—liver cancer	1.72e-05	6.31e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—GSTP1—liver cancer	1.69e-05	6.19e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—GOT2—liver cancer	1.68e-05	6.16e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—HMOX1—liver cancer	1.66e-05	6.1e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—PIK3CG—liver cancer	1.65e-05	6.07e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—MTHFR—liver cancer	1.62e-05	5.93e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—MTHFR—liver cancer	1.6e-05	5.88e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—PPARG—liver cancer	1.6e-05	5.86e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—PPARA—liver cancer	1.59e-05	5.82e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—CYP2E1—liver cancer	1.58e-05	5.79e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—PPARA—liver cancer	1.57e-05	5.77e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—GSTM1—liver cancer	1.55e-05	5.68e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.55e-05	5.68e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—PIK3CG—liver cancer	1.48e-05	5.42e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—CYCS—liver cancer	1.48e-05	5.42e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—CYP1A1—liver cancer	1.47e-05	5.39e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—PIK3CD—liver cancer	1.45e-05	5.34e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—GOT1—liver cancer	1.45e-05	5.31e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—GGT1—liver cancer	1.45e-05	5.31e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—ALB—liver cancer	1.44e-05	5.27e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—PPARG—liver cancer	1.42e-05	5.23e-05	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—PIK3CA—liver cancer	1.42e-05	5.21e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.41e-05	5.18e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—MTHFR—liver cancer	1.37e-05	5.02e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—PIK3CG—liver cancer	1.36e-05	4.98e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—PIK3CG—liver cancer	1.35e-05	4.94e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—PPARA—liver cancer	1.34e-05	4.93e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—PPARG—liver cancer	1.31e-05	4.81e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—GSTP1—liver cancer	1.3e-05	4.77e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—PPARG—liver cancer	1.3e-05	4.77e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—PIK3CD—liver cancer	1.3e-05	4.76e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—HMOX1—liver cancer	1.28e-05	4.71e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—ALB—liver cancer	1.28e-05	4.7e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—PIK3CB—liver cancer	1.27e-05	4.65e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.21e-05	4.43e-05	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—PIK3CA—liver cancer	1.2e-05	4.39e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—GSTM1—liver cancer	1.2e-05	4.39e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—PIK3CD—liver cancer	1.19e-05	4.38e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—PIK3CD—liver cancer	1.18e-05	4.34e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—ALB—liver cancer	1.18e-05	4.32e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—ALB—liver cancer	1.17e-05	4.29e-05	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—AKT1—liver cancer	1.16e-05	4.26e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—PIK3CG—liver cancer	1.15e-05	4.22e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—CYP1A1—liver cancer	1.13e-05	4.16e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—PIK3CB—liver cancer	1.13e-05	4.15e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—PPARG—liver cancer	1.11e-05	4.07e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—MTHFR—liver cancer	1.06e-05	3.88e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—PIK3CB—liver cancer	1.04e-05	3.82e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—PPARA—liver cancer	1.04e-05	3.8e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—PIK3CB—liver cancer	1.03e-05	3.78e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—PIK3CD—liver cancer	1.01e-05	3.71e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—ALB—liver cancer	9.98e-06	3.66e-05	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—AKT1—liver cancer	9.77e-06	3.59e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—PIK3CG—liver cancer	8.88e-06	3.26e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—PIK3CB—liver cancer	8.81e-06	3.23e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—PPARG—liver cancer	8.57e-06	3.14e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—PIK3CD—liver cancer	7.8e-06	2.86e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—PIK3CA—liver cancer	7.72e-06	2.83e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—ALB—liver cancer	7.7e-06	2.83e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—PIK3CA—liver cancer	6.89e-06	2.53e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—PIK3CB—liver cancer	6.8e-06	2.5e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—PIK3CA—liver cancer	6.34e-06	2.33e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—AKT1—liver cancer	6.31e-06	2.32e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—PIK3CA—liver cancer	6.29e-06	2.31e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—AKT1—liver cancer	5.63e-06	2.07e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—PIK3CA—liver cancer	5.37e-06	1.97e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—AKT1—liver cancer	5.18e-06	1.9e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—AKT1—liver cancer	5.14e-06	1.88e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—AKT1—liver cancer	4.39e-06	1.61e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—PIK3CA—liver cancer	4.15e-06	1.52e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—AKT1—liver cancer	3.39e-06	1.24e-05	CbGpPWpGaD
